BEAM-101 seems to be competitive with approved sickle cell treatments, William Blair analysts said in a note to investors, ...

Fly fishing enthusiasts seeking a once-in-a-lifetime experience in untouched wilderness will soon have a new destination: the ...

Equities researchers at William Blair raised their Q4 2024 EPS estimates for shares of Cheesecake Factory in a research note ...

However, for William “Will” Blair, it is his passion. Known for his relentless pursuit of untouched rivers and wilderness settings, Will has built a career and a lifestyle centered around ...

Investment analysts at William Blair increased their FY2024 earnings per share (EPS) estimates for Lennox International in a ...

Fintel reports that on October 30, 2024, William Blair downgraded their outlook for BioMarin Pharmaceutical (WBAG:BMRN) from Outperform to Market Perform. There are 1,150 funds or institutions ...

Photo courtesy of Republic Services Inc. Chicago-based equities advisory firm William Blair has appointed equity research analyst Trevor Romeo to initiate coverage of three companies in the solid ...

William Blair Small-Mid Cap Growth Fund earns a Below Average Process Pillar rating. The process is strengthened by its parent firm's long-term risk-adjusted performance, as shown by the firm's ...

Fintel reports that on September 18, 2024, William Blair initiated coverage of NVIDIA (WBAG:NVDA) with a Outperform recommendation. What is the Fund Sentiment? There are 6,506 funds or ...

William Blair Small-Mid Cap Growth Fund earns a Below Average Process Pillar rating. The process is strengthened by its parent firm's long-term risk-adjusted performance, as shown by the firm's ...

The Fund seeks long-term capital appreciation. Under normal conditions, the Fund invests primarily in a diversified portfolio of equity securities, including common stocks and other forms of ...